Global Women’s Health Drugs Market to 2024 – Influx of New Products Including Orilissa, Relugolix and Bremelanotide

Global Women’s Health Drugs Market to 2024 Research Report provides Key Marketed Products, Pipeline Landscape Assessment, Company Analysis and Positioning, Revenue and Market Share and Strategic Consolidations.

Pune, India - February 12, 2019 /MarketersMedia/ —

The women’s health therapy area covers medical disorders that affect females only, primarily disorders of the female reproductive system, including those associated with menstruation, conception, pregnancy, childbirth and menopause. Many of these disorders are highly prevalent among the female population.

The Women’s Health Market is relatively small considering the high prevalence of many women’s health indications. However, robust growth is projected over the forecast period due to the influx of a number of new products.

This report covers all indications within women’s health with a particular focus on five key indications: endometriosis, polycystic ovarian syndrome (PCOS), cervical intraepithelial neoplasia (CIN), menopausal disorders and infertility.

*Company Analysis and Positioning:
Revenue and Market Share Analysis by Company
1 Bayer AG - Company to Remain a Market Leader within Women’s Health
2 AbbVie Inc - Orilissa to Reach Blockbuster Status, Boosting Company’s Market Share
3 Allergan - Revenue Gains From Fibristal, Lo Loestrin Fe and Liletta to Offset Losses from Minastrin 24 Fe and Estrace
4 Merck & Co. - Company to Remain a Key Player Due to Growth of Gardasil/Gardasil 9
5 GlaxoSmithKline - Cervarix and Retosiban to Drive Strong Growth
6 Pfizer - How will patent expiration affect revenues for women’s health market?
7 TherapeuticsMD – Women’s Health Specialist to Gain Considerable Market Share by 2024

Get Discount on Global Women’s Health Drugs Market Research Report at https://www.reportsnreports.com/contacts/discount.aspx?name=1854865

Scope
- There are 277 pipeline products in active development for women’s health disorders. Which molecule types and molecular targets are most prominent within the pipeline?
- Merck&Co and Bayer currently represent leading companies within women’s health. Will they maintain this dominance over the forecast period?
- Gardasil, Mirena and Nuvaring and are among the most lucrative drugs within the women’s health market. Which of these will experience a considerable decline in revenue over the forecast period following loss of patent protection?
- The influx of a number of recent market entrants and late-stage pipeline products will have a considerable impact on the women’s health market over the forecast period. Which of these drugs are projected to achieve blockbuster status by 2024?
- In total, 246 licensing deals relating to women’s health products have been completed since 2006. Which types of assets attracted the largest deal values?

Direct Purchase of this Research Report at https://www.reportsnreports.com/purchase.aspx?name=1854865

Reasons to buy:
- Understand the current treatment landscape, with portfolios of key marketed products and a focus on historical and forecast sales patterns, and an overview of each drug’s mechanism of action.
- Analyze the women’s health pipeline through a comprehensive review of the pipeline segmented by stage of development, molecule type and molecular target.
- Consider market opportunities and potential risks by examining trends in clinical trial duration and size, as well as clinical trial failure rates.
- Predict growth in market size by examining multi-scenario forecasting trends from 2017 to 2024 and determine the contributions that different products and companies will make to this growth.
- Identify commercial opportunities in the women’s health deals landscape by analyzing trends in licensing and co-development deals.

Contact Info:
Name: Vishal Kalra
Email: Send Email
Organization: ReportsnReports
Website: https://www.reportsnreports.com/reports/1854865-global-womens-health-drugs-market-to-2024-influx-of-new-products-including-orilissa-relugolix-and-bremelanotide-to-diversify-landscape-and-drive-growth.html

Source URL: https://marketersmedia.com/global-womens-health-drugs-market-to-2024-influx-of-new-products-including-orilissa-relugolix-and-bremelanotide/481772

Source: MarketersMedia

Release ID: 481772

Latest News

Shanahan tells Naval Academy graduates to change status quo

May 25, 2019

ANNAPOLIS, Md. — Acting Defense Secretary Patrick Shanahan told graduates at the U.S. Naval Academy on Friday to change the status quo and stand their ground in the face of ethical failure, urging them to "set the standard on preventing sexual harassment and assault" among ranks. He called on midshipmen to "set the climate," transform the U.S. Navy and Marine Corps, and be an example for subordinates, peers and leaders. "When you see ethical failure — in uniform or out, by military members or others — you must become gravity. You and your commitment must be unshakable, regardless of the...

CEOs get $800,000 pay raise, leaving workers further behind

May 25, 2019

NEW YORK — Did you get a 7% raise last year? Congratulations, yours was in line with what CEOs at the biggest companies got. But for chief executives, that 7% was roughly $800,000. Pay for CEOs at S&P 500 companies rose to a median of $12 million last year, including salary, stock and other compensation, according to data analyzed by Equilar for The Associated Press. The eight-figure packages continue to rise as companies tie more of their CEOs' pay to their stock prices, which are still near record levels, and as profits hit an all-time high last year due to...

After shark attacks, is Cape Cod ready for tourist season?

May 25, 2019

WELLFLEET, Mass. — As Cape Cod's tourist season gets underway, there's uncertainty after two shark attacks — including Massachusetts' first fatal attack since 1936 — rattled beachgoers last year and sparked a still unresolved debate about how the vacation destination should respond. Among the questions on many minds this Memorial Day holiday weekend: Will there be more attacks? Will the region's billion-dollar tourism economy take a hit as scared beachgoers stay away? And is there anything that can be done to make the sea safer? At Longnook Beach in Truro, where a New York man was badly mauled by a...

Virtual reality helps police learn to interact with autistic

May 25, 2019

WASHINGTON — An autistic man walks out of a store without paying for a toy he picked up. He's followed by a storekeeper demanding he come back inside. The situation quickly escalates, and police are called. Officers arrive, their patrol car's lights flashing and sirens blaring, to find the man in the parking lot, yelling and not responding to their commands. They have a choice: confront the man and risk having the situation turn violent or regroup to figure out a different approach. The scenario is part of a virtual reality simulation for police that's being developed by Axon —...

US withdraws train crew proposal that came after explosions

May 25, 2019

BILLINGS, Mont. — The Trump administration said Thursday it was withdrawing a proposal for freight trains to have at least two crew members, nullifying a safety measure drafted under President Barack Obama in response to explosions of crude oil trains in the U.S. and Canada. A review of accident data did not support the notion that having one crew member is less safe than multi-person crews, Department of Transportation officials said. The withdrawal also seeks to pre-empt states from regulating crew sizes. The 2016 proposal followed oil train derailments including a runaway oil train in 2013 that derailed, exploded and...

The Next Daily is the new generation of online publication, serving you the most recent discoveries made in science and technology on a daily basis. At The Next Daily, we believe in the power of consistent and reliable reporting to inspire and move mankind forward.

Contact us: sales[at]thenextdaily.com